Results 231 to 240 of about 93,221 (259)

Temozolomide

Reactions Weekly, 2015
  +4 more sources

Temozolomide

Reactions Weekly, 2011
  +4 more sources

Management of glioblastoma: State of the art and future directions

Ca-A Cancer Journal for Clinicians, 2020
Aaron Tan, David M Ashley, Giselle Lopez
exaly  

Temozolomide

Reactions Weekly, 2023
openaire   +1 more source

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial

Autophagy, 2021
Inge Compter, Kasper M A Rouschop, Pieter Wesseling   +2 more
exaly  

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

Lancet Oncology, The, 2021
Wolfgang Wick, Alba Ariela Brandes, Anna K Nowak   +2 more
exaly  

Temozolomide

Reactions Weekly, 2016
openaire   +2 more sources

Temozolomide

Reactions Weekly, 2018
openaire   +2 more sources

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Lancet, The, 2019
Ulrich Herrlinger, Theophilos Tzaridis, Rolf-Dieter Kortmann   +2 more
exaly  

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

New England Journal of Medicine, 2014
Wolfgang Wick, Warren Mason, Frank Saran
exaly